Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH) and Dexcom (DXCM)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cardinal Health (CAH) and Dexcom (DXCM) with bullish sentiments.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cardinal Health (CAH)
Argus Research analyst Steven Silver maintained a Buy rating on Cardinal Health on May 5 and set a price target of $248.00. The company’s shares closed last Monday at $182.50.
Silver has an average return of
According to TipRanks.com, Silver is ranked #4294 out of 12246 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cardinal Health with a $246.00 average price target, representing a 33.3% upside. In a report issued on April 28, William Blair also initiated coverage with a Buy rating on the stock.
See the top stocks recommended by analysts >>
Read More on CAH:
Disclaimer & DisclosureReport an Issue
- Cencora price target lowered to $331 from $429 at Wells Fargo
- Cardinal Health price target lowered to $215 from $243 at JPMorgan
- Cardinal, McKesson, Zeta, Centene, ABAT Trending With Analysts
- Cardinal Health price target lowered to $248 from $257 at Baird
- Cardinal Health price target raised to $255 from $251 at TD Cowen
